{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    45,
    46,
    47,
    48
  ],
  "modelUsed": "claude-opus-4-5",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Evobrutinib 45 mg",
        "role": {
          "code": "Investigational Product",
          "codeSystem": "USDM",
          "decode": "Investigational Product"
        },
        "instanceType": "StudyIntervention",
        "description": "Therapeutic dose of evobrutinib administered as oral solution under fasted conditions",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Evobrutinib 225 mg",
        "role": {
          "code": "Investigational Product",
          "codeSystem": "USDM",
          "decode": "Investigational Product"
        },
        "instanceType": "StudyIntervention",
        "description": "Supratherapeutic dose of evobrutinib administered as oral solution under fasted conditions",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Placebo",
        "role": {
          "code": "Placebo",
          "codeSystem": "USDM",
          "decode": "Placebo"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo oral solution administered under fasted conditions",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Moxifloxacin 400 mg",
        "role": {
          "code": "Comparator",
          "codeSystem": "USDM",
          "decode": "Comparator"
        },
        "instanceType": "StudyIntervention",
        "description": "Positive control for QTc assay sensitivity administered as oral tablet under fasted conditions",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Evobrutinib oral solution 45 mg",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Solution",
          "codeSystem": "USDM",
          "decode": "Solution"
        },
        "strength": "45 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Merck Healthcare KGaA; powder in bottle formulation and oral solution manufactured by Nuvisan"
      },
      {
        "id": "prod_2",
        "name": "Evobrutinib oral solution 225 mg",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Solution",
          "codeSystem": "USDM",
          "decode": "Solution"
        },
        "strength": "225 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Merck Healthcare KGaA; powder in bottle formulation and oral solution manufactured by Nuvisan"
      },
      {
        "id": "prod_3",
        "name": "Placebo oral solution",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Solution",
          "codeSystem": "USDM",
          "decode": "Solution"
        },
        "strength": "N/A",
        "manufacturer": "Nuvisan GmbH"
      },
      {
        "id": "prod_4",
        "name": "Moxifloxacin 400 mg film-coated tablets",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Tablet",
          "codeSystem": "USDM",
          "decode": "Tablet"
        },
        "strength": "400 mg",
        "manufacturer": "Nuvisan GmbH (commercial product from German market)"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Evobrutinib 45 mg single dose",
        "instanceType": "Administration",
        "dose": "45 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_2",
        "name": "Evobrutinib 225 mg single dose",
        "instanceType": "Administration",
        "dose": "225 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_3",
        "name": "Placebo single dose",
        "instanceType": "Administration",
        "dose": "N/A",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_4",
        "name": "Moxifloxacin 400 mg single dose",
        "instanceType": "Administration",
        "dose": "400 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Single administration per treatment period"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Evobrutinib",
        "instanceType": "Substance",
        "description": "Oral, selective, irreversible inhibitor of BTK (also known as M2951 and MSC2364447C)"
      },
      {
        "id": "sub_2",
        "name": "Moxifloxacin",
        "instanceType": "Substance",
        "description": "Fluoroquinolone antibiotic used as positive control for QTc prolongation assessment"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 4,
      "productCount": 4,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Evobrutinib 45 mg",
        "role": "Investigational Product",
        "description": "Therapeutic dose of evobrutinib administered as oral solution under fasted conditions"
      },
      {
        "name": "Evobrutinib 225 mg",
        "role": "Investigational Product",
        "description": "Supratherapeutic dose of evobrutinib administered as oral solution under fasted conditions"
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo oral solution administered under fasted conditions"
      },
      {
        "name": "Moxifloxacin 400 mg",
        "role": "Comparator",
        "description": "Positive control for QTc assay sensitivity administered as oral tablet under fasted conditions"
      }
    ],
    "products": [
      {
        "name": "Evobrutinib oral solution 45 mg",
        "doseForm": "Solution",
        "strength": "45 mg",
        "manufacturer": "Merck Healthcare KGaA; powder in bottle formulation and oral solution manufactured by Nuvisan"
      },
      {
        "name": "Evobrutinib oral solution 225 mg",
        "doseForm": "Solution",
        "strength": "225 mg",
        "manufacturer": "Merck Healthcare KGaA; powder in bottle formulation and oral solution manufactured by Nuvisan"
      },
      {
        "name": "Placebo oral solution",
        "doseForm": "Solution",
        "strength": "N/A",
        "manufacturer": "Nuvisan GmbH"
      },
      {
        "name": "Moxifloxacin 400 mg film-coated tablets",
        "doseForm": "Tablet",
        "strength": "400 mg",
        "manufacturer": "Nuvisan GmbH (commercial product from German market)"
      }
    ],
    "substances": [
      {
        "name": "Evobrutinib",
        "description": "Oral, selective, irreversible inhibitor of BTK (also known as M2951 and MSC2364447C)"
      },
      {
        "name": "Moxifloxacin",
        "description": "Fluoroquinolone antibiotic used as positive control for QTc prolongation assessment"
      }
    ],
    "administrations": [
      {
        "name": "Evobrutinib 45 mg single dose",
        "dose": "45 mg",
        "frequency": "Single dose",
        "route": "Oral",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "Evobrutinib 225 mg single dose",
        "dose": "225 mg",
        "frequency": "Single dose",
        "route": "Oral",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "Placebo single dose",
        "dose": "N/A",
        "frequency": "Single dose",
        "route": "Oral",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "Moxifloxacin 400 mg single dose",
        "dose": "400 mg",
        "frequency": "Single dose",
        "route": "Oral",
        "duration": "Single administration per treatment period"
      }
    ],
    "devices": []
  }
}